Scientific research innovation

Classical findings - Classical innovation - Scientific verification
Cultivating cost and scale advantages with disruptive technologies


Yifan is an innovative pharmaceutical enterprise focusing on the health field (securities code 002019, securities abbreviation: Yifan pharmaceutical).
Our vision is to develop innovative drugs with definite clinical values, to help disease-afflicted patients regain health.
Currently, we are focusing on four business areas, i.e., macromolecules, small molecules, synthetic biologics, and special traditional Chinese medicines (TCMs), expanding our product R&D pipelines and innovating drugs for disease treatment to address unmet medical needs; and we are striving to set up an extensive commercial network to facilitate the flow of quality drugs having reliable therapeutic effect across the world to help cure diseases.